Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;308(2):569-577.
doi: 10.1007/s00404-023-07047-z. Epub 2023 May 9.

The association between the type of progesterone supplementation and miscarriage risk in women who have had a positive pregnancy test following embryo transfer: a retrospective cohort study

Talya Shaulov  1   2 , Nadège Zanré  3 , Simon Phillips  4 , Louise Lapensée  4   3
Affiliations

The association between the type of progesterone supplementation and miscarriage risk in women who have had a positive pregnancy test following embryo transfer: a retrospective cohort study

Talya Shaulov et al. Arch Gynecol Obstet. 2023 Aug.

Abstract

Purpose: The purpose of this study was to identify if switching from intramuscular (IM) to vaginal progesterone compared to staying on IM progesterone after a positive pregnancy test following embryo transfer (ET) is associated with miscarriage risk.

Methods: A retrospective cohort study was performed in a private university-affiliated fertility clinic and included women aged 18-50 years with a positive pregnancy test following ET. The two groups studied were: women who stayed on IM progesterone following a positive pregnancy test and those who switched to vaginal progesterone after a positive test. The main outcome measured was risk of miscarriage < 24 weeks gestation as a proportion of non-biochemical pregnancies.

Results: 1988 women were included in the analysis. Among the baseline characteristics, the presence of prior miscarriages as well as prior failed ETs, and frozen cycles (vs fresh) as type of transfer were associated with IM progesterone use (p values ≤ 0.01). As per miscarriage risk < 24 weeks, 22.4% (274/1221) of patients in the IM progesterone group experienced a miscarriage compared with 20.7% (159/767) in the vaginal progesterone group (OR 0.90; 95% CI 0.73-1.13). A multivariable logistic regression model revealed an adjusted OR (aOR) of 0.97 (95% CI 0.77-1.22).

Conclusion: This study suggests that switching from IM to vaginal progesterone after a positive pregnancy test following an ET is not associated with miscarriage risk. Considering that IM progesterone imposes substantial discomfort, this study offers reassurance and some flexibility in treatment protocols. Further prospective studies are necessary to corroborate the results of this study.

Keywords: In vitro fertilization; Intramuscular progesterone; Luteal phase support; Miscarriage; Vaginal progesterone.

PubMed Disclaimer

References

    1. Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P (2007) An update of luteal phase support in stimulated IVF cycles. Hum Reprod Update 13(6):581–590. https://doi.org/10.1093/humupd/dmm021 - DOI - PubMed
    1. van der Linden M, Buckingham K, Farquhar C, Kremer JAM (2015) Metwally M (2015) Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 7:CD009154
    1. Beltsos AN, Sanchez MD, Doody KJ, Bush MR, Domar AD, Collins MG (2014) Patients’ administration preferences: progesterone vaginal insert (Endometrin(R)) compared to intramuscular progesterone for Luteal phase support. Reprod Health 11:78. https://doi.org/10.1186/1742-4755-11-78 - DOI - PubMed - PMC
    1. Propst AM, Hill JA, Ginsburg ES, Hurwitz S, Politch J, Yanushpolsky EH (2001) A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril 76(6):1144–1149. https://doi.org/10.1016/s0015-0282(01)02872-2 - DOI - PubMed
    1. Doody K, Bush M, Collins M (2012) Progesterone supplementation for luteal support: efficacy and patient experiences with vaginal inserts (Endometrin®) versus intramuscular injection. Fertil Steril 97(3):S18. https://doi.org/10.1016/j.fertnstert.2012.01.040 - DOI

LinkOut - more resources